O. Yıldız, M. Karakurt Eryılmaz, T. Aykut, Ömer Genç, B. E. Kaya, and A. F. Gürbüz, “Reduced efficacy of nivolumab following prior immunotherapy in metastatic renal cell carcinoma: Implications for sequential immune checkpoint inhibition”, Exp Biomed Res, vol. 9, no. 1, pp. 1–9, Jan. 2026.